Brief: Unichem Laboratories Receives ANDA Approval For Ranolazine Extended-Release Tablets, 500 Mg And 1000 Mg
17/03/2023 06:08
March 17 (Reuters) - Unichem Laboratories Ltd UNLB.NS :
* UNICHEM LABORATORIES LTD - RECEIVED ANDA APPROVAL FOR
RANOLAZINE
EXTENDED-RELEASE TABLETS, 500 MG AND 1000 MG
* UNICHEM LABORATORIES LTD - APPROVAL RECEIVED FROM USFDA
Source text for Eikon: ID:nBSE6hL397
Further company coverage: UNLB.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Unichem Laboratories
See all newsIndia's Unichem Laboratories drops after US FDA inspection ends with five observations
India's Unichem Labs falls after appeal against tax demand rejected
Brief: Unichem Laboratories June-Quarter Consol PAT 414.7 Million Rupees
India's Unichem Laboratories jumps on posting Q1 profit
India's Unichem Laboratories surges in busiest session ever after block deal at premium